SCHEMBL8879064

SCHEMBL8879064

O=C(O)N(CCN(Cc1ccccc1)Cc1ccccc1)CC1CCc2ccccc2O1

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.46
SIGMAR1 Q99720 2/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
CA2 P00918 2/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
DRD2 P14416 4/20 0.40
DRD4 P21917 4/20 0.40
DRD3 P35462 4/20 0.40
DRD1 P21728 2/20 0.40
DRD5 P21918 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9033661 0.88 HTR1A (0.40) HTR1ASIGMAR1ADRA2AADRA2BADRA2C
SCHEMBL8880016 0.84 CA2 (0.50) HTR1ASIGMAR1ADRA2AADRA2BADRA2C
SCHEMBL8044366 0.78 HTR1A (0.46) HTR1ASIGMAR1ADRA2AADRA2BADRA2C
SCHEMBL8052466 0.77 HTR1A (0.46) HTR1ASIGMAR1ADRA2AADRA2BADRA2C
SCHEMBL8863957 0.77 HTR1A (0.46) HTR1ASIGMAR1ADRA2AADRA2BADRA2C
SCHEMBL8878969 0.75 HTR1A (0.44) HTR1ASIGMAR1ADRA2AADRA2BADRA2C
SCHEMBL8863858 0.73 HTR1A (0.61) HTR1A
SCHEMBL4934556 0.73 CA2 (0.45) HTR1ASIGMAR1ADRA2AADRA2BADRA2C
SCHEMBL5723845 0.73 HTR1A (0.43) HTR1ASIGMAR1ADRA2AADRA2BADRA2C
SCHEMBL5722960 0.73 HTR1A (0.40) HTR1ASIGMAR1ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624952-A VASOCONSTRICTORS JANSSEN PHARMACEUTICA N.V. (BE) 1997-04-29 US disclosed
US-5607949-A VASOCONTRICTORS, TREATING MIGRAIN JANSSEN PHARMACEUTICA N.V. (BE) 1997-03-04 US disclosed
US-5541180-A HEADACHE THERAPY JANSSEN PHARMACEUTICA N.V. (BE) 1996-07-30 US disclosed